Antioxidant Composition for Aminoglycoside-Induced Hearing Loss
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for treating hearing loss induced by aminoglycoside antibiotics are inadequate, leading to significant side effects such as permanent vestibular deficits and irreversible cell death in the cochlea, particularly in developing countries where monitoring is less rigorous.
Innovation Solution
A composition comprising biologically effective amounts of vitamin A, vitamin E, vitamin C, and a vasodilator like magnesium, optionally with anolid and/or resveratrol, which provides an additive effect greater than the sum of individual components in reducing hearing loss and associated side effects.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If aminoglycoside antibiotics are used to treat severe gram-negative bacterial infections, then treatment effectiveness is improved, but hearing loss and vestibular damage occur
Solution Approach 1:
The patent introduces antioxidant agents (vitamin E, vitamin C, beta-carotene, allopurinol) as intermediary substances that mediate between the aminoglycoside antibiotic and the cochlear hair cells. These antioxidants scavenge free radicals and prevent direct toxic damage, allowing the antibiotic to maintain its therapeutic effectiveness while protecting the ear from ototoxicity.
Solution Approach 2:
The patent converts the harmful free radical formation caused by aminoglycoside antibiotics into a beneficial target for antioxidant intervention. By scavenging the free radicals that would otherwise cause cell death, the antioxidants transform the toxic mechanism into a controllable process, reducing hearing loss while preserving antibiotic efficacy.
2Object-affected harmful factors
If free radical scavengers are administered to reduce ototoxicity, then hearing loss is reduced, but the composition complexity increases
Solution Approach 1:
The patent merges multiple free radical scavenging mechanisms into a single composite treatment formulation. By combining vitamin E (lipid-soluble), vitamin C (water-soluble), beta-carotene, and allopurinol into one administered composition, the patent simplifies the clinical approach compared to administering separate antioxidant agents, while maintaining comprehensive protection against ototoxicity.
Solution Approach 2:
The composite antioxidant formulation serves multiple functions simultaneously: vitamin E and beta-carotene protect lipid membranes from peroxidation, vitamin C scavenges water-soluble free radicals and regenerates vitamin E, and allopurinol inhibits xanthine oxidase. This multi-functional approach reduces the need for multiple separate treatments.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The composition effectively reduces noise-induced and antibiotic-induced hearing loss by counteracting free radical formation and vasoconstriction, resulting in significant protection of hair cells and improved auditory thresholds.
Implementation Method 1
The composition effectively reduces noise-induced and antibiotic-induced hearing loss by counteracting free radical formation
Implementation Method 2
a vasodilator like magnesium, optionally with anolid and/or resveratrol, which provides an additive effect greater than the sum of individual components in reducing hearing loss
Data Source
AI summary
A composition to be administered to a mammal for treating hearing loss is disclosed herein. The composition consists essentially of a biologically effective amount of vitamin A, vitamin C, vitamin E, and a vasodilator comprising magnesium. The composition optionally includes a withanolide and/or resveratrol. The vitamin A, vitamin C, vitamin E, and the vasodilator comprising magnesium provides an additive effect that is equal to or greater than a sum of the effects of the individual components.